AllergoOncology: Generating a canine anti-cancer IgE against the epidermal growth factor receptor (EGFR): Generating a canine anticancer IgE against the epidermal growth factor receptor

Judit Fazekas-Singer; Josef Singer; Kristina M. Ilieva; Miroslawa Matz; Ina Herrmann; Edzard Spillner; Sophia N. Karagiannis; Erika Jensen-Jarolim

doi:10.1016/j.jaci.2018.04.021

AllergoOncology: Generating a canine anti-cancer IgE against the epidermal growth factor receptor (EGFR): Generating a canine anticancer IgE against the epidermal growth factor receptor

Judit Fazekas-Singer, Josef Singer, Kristina M. Ilieva, Miroslawa Matz, Ina Herrmann, Edzard Spillner, Sophia N. Karagiannis, Erika Jensen-Jarolim

Dermatology

Research output: Contribution to journal › Letter › peer-review

12 Citations (Scopus)

198 Downloads (Pure)

Abstract

Anti-cancer immunotherapies currently rely on IgG antibodies. In line with the AllergoOncology concept we provide evidence that tumor-specific IgE, alone or combined with IgG, may be superior to IgG treatment alone. The novel can225IgE-λ was made for future studies in dogs as translational model patients.

Original language	English
Journal	Journal of Allergy and Clinical Immunology
Early online date	7 May 2018
DOIs	https://doi.org/10.1016/j.jaci.2018.04.021
Publication status	E-pub ahead of print - 7 May 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaci.2018.04.021Licence: CC BY-NC-ND

AllergoOncology: Generating a canine_FAZEKAS-SINGER_Accepted1January2018_GOLD VoR (CC BY-NC-ND)Final published version, 1.78 MBLicence: CC BY-NC-ND

Cite this

Fazekas-Singer, J., Singer, J., Ilieva, K. M., Matz, M., Herrmann, I., Spillner, E., Karagiannis, S. N., & Jensen-Jarolim, E. (2018). AllergoOncology: Generating a canine anti-cancer IgE against the epidermal growth factor receptor (EGFR): Generating a canine anticancer IgE against the epidermal growth factor receptor. Journal of Allergy and Clinical Immunology. Advance online publication. https://doi.org/10.1016/j.jaci.2018.04.021

@article{f1c01eedd30e45ffaa8372073fa54f48,

title = "AllergoOncology: Generating a canine anti-cancer IgE against the epidermal growth factor receptor (EGFR): Generating a canine anticancer IgE against the epidermal growth factor receptor",

abstract = "Anti-cancer immunotherapies currently rely on IgG antibodies. In line with the AllergoOncology concept we provide evidence that tumor-specific IgE, alone or combined with IgG, may be superior to IgG treatment alone. The novel can225IgE-λ was made for future studies in dogs as translational model patients.",

author = "Judit Fazekas-Singer and Josef Singer and Ilieva, {Kristina M.} and Miroslawa Matz and Ina Herrmann and Edzard Spillner and Karagiannis, {Sophia N.} and Erika Jensen-Jarolim",

note = "Copyright {\textcopyright} 2018. Published by Elsevier Inc.",

year = "2018",

month = may,

day = "7",

doi = "10.1016/j.jaci.2018.04.021",

language = "English",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier",

}

Fazekas-Singer, J, Singer, J, Ilieva, KM, Matz, M, Herrmann, I, Spillner, E, Karagiannis, SN & Jensen-Jarolim, E 2018, 'AllergoOncology: Generating a canine anti-cancer IgE against the epidermal growth factor receptor (EGFR): Generating a canine anticancer IgE against the epidermal growth factor receptor', Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2018.04.021

AllergoOncology: Generating a canine anti-cancer IgE against the epidermal growth factor receptor (EGFR): Generating a canine anticancer IgE against the epidermal growth factor receptor. / Fazekas-Singer, Judit; Singer, Josef; Ilieva, Kristina M. et al.
In: Journal of Allergy and Clinical Immunology, 07.05.2018.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - AllergoOncology: Generating a canine anti-cancer IgE against the epidermal growth factor receptor (EGFR)

T2 - Generating a canine anticancer IgE against the epidermal growth factor receptor

AU - Fazekas-Singer, Judit

AU - Singer, Josef

AU - Ilieva, Kristina M.

AU - Matz, Miroslawa

AU - Herrmann, Ina

AU - Spillner, Edzard

AU - Karagiannis, Sophia N.

AU - Jensen-Jarolim, Erika

PY - 2018/5/7

Y1 - 2018/5/7

N2 - Anti-cancer immunotherapies currently rely on IgG antibodies. In line with the AllergoOncology concept we provide evidence that tumor-specific IgE, alone or combined with IgG, may be superior to IgG treatment alone. The novel can225IgE-λ was made for future studies in dogs as translational model patients.

AB - Anti-cancer immunotherapies currently rely on IgG antibodies. In line with the AllergoOncology concept we provide evidence that tumor-specific IgE, alone or combined with IgG, may be superior to IgG treatment alone. The novel can225IgE-λ was made for future studies in dogs as translational model patients.

U2 - 10.1016/j.jaci.2018.04.021

DO - 10.1016/j.jaci.2018.04.021

M3 - Letter

C2 - 29746883

SN - 0091-6749

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

ER -

AllergoOncology: Generating a canine anti-cancer IgE against the epidermal growth factor receptor (EGFR): Generating a canine anticancer IgE against the epidermal growth factor receptor

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this